The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharon, J.
Right arrow Articles by Margolies, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharon, J.
Right arrow Articles by Margolies, M. N.

The Journal of Immunology, Vol 142, Issue 2 596-601, Copyright © 1989 by American Association of Immunologists


ARTICLES

Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten

J Sharon, ML Gefter, LJ Wysocki and MN Margolies
Department of Pathology, Hubert H. Humphrey Cancer Research Center, Boston, MA 02118.

Two mouse mAb specific for the hapten p-azophenylarsonate and encoded by the same combination of germ-line V, D, and J genes differ 200-fold in affinity for hapten. We determined the amino acid sequences of the V regions of the high affinity antibody and compared them to the published sequences of the low affinity antibody which is not somatically mutated. Of 19 amino acid substitutions, two, Ile57 and Thr58 in the H chain, also occur, either alone or together, in other somatically mutated antibodies specific for p-azophenylarsonate; these antibodies have been independently isolated. Introduction of either one of these mutations alone into the low affinity antibody by oligonucleotide-directed mutagenesis increased the antibody affinity for hapten three- to fourfold, whereas introduction of both mutations together conferred an eightfold increase in affinity. These results support the hypothesis that somatic mutations are selected on the basis of the affinity for antigen that they confer, and suggest that even relatively small increases in affinity may be selected, probably in a sequential manner.


This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Aviszus, X. Zhang, and L. J. Wysocki
Silent Development of Memory Progenitor B Cells
J. Immunol., October 15, 2007; 179(8): 5181 - 5190.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Short, R. A. Krykbaev, P. D. Jeffrey, and M. N. Margolies
Complementary Combining Site Contact Residue Mutations of the Anti-digoxin Fab 26-10 Permit High Affinity Wild-type Binding
J. Biol. Chem., May 3, 2002; 277(19): 16365 - 16370.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Parhami-Seren, M. Viswanathan, R. K. Strong, and M. N. Margolies
Structural Analysis of Mutants of High-Affinity and Low-Affinity p-Azophenylarsonate-Specific Antibodies Generated by Alanine Scanning of Heavy Chain Complementarity-Determining Region 2
J. Immunol., November 1, 2001; 167(9): 5129 - 5135.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. D. Wiens, A. Lekkerkerker, I. Veltman, and M. B. Rittenberg
Mutation of a Single Conserved Residue in VH Complementarity-Determining Region 2 Results in a Severe Ig Secretion Defect
J. Immunol., August 15, 2001; 167(4): 2179 - 2186.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
M.K. Short, P.D. Jeffrey, A. Demirjian, and M.N. Margolies
A single H:CDR3 residue in the anti-digoxin antibody 26-10 modulates specificity for C16-substituted digoxin analogs
Protein Eng. Des. Sel., April 1, 2001; 14(4): 287 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Vora, K. Tumas-Brundage, and T. Manser
Contrasting the In Situ Behavior of a Memory B Cell Clone During Primary and Secondary Immune Responses
J. Immunol., October 15, 1999; 163(8): 4315 - 4327.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. England, R. Nageotte, M. Renard, A.-L. Page, and H. Bedouelle
Functional Characterization of the Somatic Hypermutation Process Leading to Antibody D1.3, a High Affinity Antibody Directed Against Lysozyme
J. Immunol., February 15, 1999; 162(4): 2129 - 2136.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. Tumas-Brundage and T. Manser
The Transcriptional Promoter Regulates Hypermutation of the Antibody Heavy Chain Locus
J. Exp. Med., January 20, 1997; 185(2): 239 - 250.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. French, R Laskov, and M. Scharff
The role of somatic hypermutation in the generation of antibody diversity
Science, June 9, 1989; 244(4909): 1152 - 1157.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.